Testing an Arts-based Program to Reduce Nurse Stigma Towards Perinatal Substance Use

Not Applicable

Completed

• Conditions: Stigma, Social; Nurse's Role; Implicit Bias
• Interventions: Other: ArtSpective

• Registration Number: NCT06410287
• Lead Sponsor: University of Michigan

Brief Summary

The goal of this pilot clinical trial is to evaluate the feasibility and limited effectiveness of a digital, arts-based educational intervention addressing nurse stigma towards perinatal substance use. The main questions it aims to answer are:

* What is the the feasibility of delivering the training through an asynchronous, web-based platform?

* What is the limited effectiveness of the program on nurse stigma towards perinatal substance use?

Participants will access and complete the training, including completion of a perinatal substance use stigma scale at baseline, immediately post, and 1-2 months month later. Participants will also be invited to participate in an interview.

Researchers will compare the intervention and control groups to see if the training reduces nurse stigma towards perinatal substance use.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2024-05-07
• Study First Submitted QC: 2024-05-10
• Study First Posted: 2024-05-13
• Study Start: 2024-07-01
• Primary Completion: 2024-11-30
• Study Completion: 2024-11-30
• Status Verified: 2024-12
• Last Update Submitted: 2024-12-17
• Last Update Posted: 2024-12-20

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Age 18 years or older
• Licensed as a registered nurse
• Works at least part time
• Works on a labor, postpartum, nursery, neonatal intensive care, or pediatric unit in one of the participating hospitals

Read More

Exclusion Criteria

• Works as per diem or agency nurse
• Not employed by a participating hospital
• Not a perinatal/pediatric nurse

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Site 2	ArtSpective	Participants from the hospital randomized to the control setting will receive an invitation to complete a survey that collects baseline data for the outcome (stigma toward perinatal substance use) and demographic information. After thirty days, participants will be invited to complete the web-based educational program. Thirty days after completion, they will receive a link to a web-based follow up survey.
Site 1	ArtSpective	Participants from the hospital randomized to the experimental group will be first to receive an invitation to complete the web-based educational program. The program will be open for one month. Thirty days after a participant completes the program, they will be sent a link to a follow up survey (web-based). At 60 days, participants who completed the program and the first follow up survey will be randomized to complete a second follow up survey or participate in a 1:1 interview.

Primary Outcome Measures

Name	Time	Method
Nurse Stigma toward Perinatal Substance Use	Measured at baseline, immediately post intervention, 30 days post, and 60 days post	Negative or stigmatizing attitudes and/or beliefs registered nurses have towards perinatal substance use; measured using the Modified Attitudes About Drug Use in Pregnancy Scale. Total scores range between 1 and 5, with scores closer to 1 associated with a more positive outcome.

Secondary Outcome Measures

Name	Time	Method
Acceptability	immediately post intervention	The level of satisfaction participants have towards the intervention; measured using an adapted version of the Abbreviated Acceptability Rating Profile. Total scores range from 1 to 5 with scores closer to 5 representing a more positive outcome.

Trial Locations

Locations (2)

ProMedica Toledo Hospital; 🇺🇸 Toledo, Ohio, United States

St. Cloud Hospital; 🇺🇸 Saint Cloud, Minnesota, United States